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Aneurysms of saphenous vein grafts are rare but can result in complications such as myocardial infarction or death. Percutaneous
treatment has included a variety of approaches, including covered stents. Long aneurysms in saphenous vein grafts pose an
additional challenge due to the lack of coronary covered stents with suﬃcient length. We present successful treatment of a long
saphenous vein graft aneurysm with use of peripheral covered stents over two coronary guidewires, a 55-centimeter 8-French
sheath and no guide catheter.
Copyright © 2009 Carmelo J. Panetta et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Saphenous vein graft (SVG) aneurysm is a rare complication
presenting in a variety of ways including an abnormality
on chest X-ray, myocardial ischemia, or graft rupture [1–
3]. Surgical revision is often recommended but often carries
a high risk [3]. Percutaneous approaches have included
covered stents, use of a vascular plug, or coiling of the
aneurysm[4–13].Theseapproachesaresuccessfulforsacular
aneurysms, but fusiform aneurysms can pose a problem due
to limited length of coronary covered stents. One successful
approach was the use of a long Wallstent to act as a scaﬀold
in the aneurysm and then deploy multiple coronary covered
stents within the Wallstent [13]. We report the successful
coverage of a fusiform saphenous vein graft aneurysm with
use of peripheral Viabahn covered stents (Figure 1)o v e r
two coronary guidewires for adequate support via a 55-
centimeter (cm) 8-French sheath without a guide catheter.
2.CaseReport
2.1. History. The patient is a 74-year-old man with his-
tory of coronary artery bypass surgery in 1988 with a
known ectatic and degenerative SVG to the right posterior
descending coronary artery (PDA). He presented in January
2008 with progressive right-sided pleuritic chest pain and
peripheral edema. A chest X-ray revealed a rounded mass
3.7cm in diameter along with right boarder. Follow up
computer tomography (CT) scan of the chest revealed a
mass worrisome for an SVG aneurysm estimated 3.1cm in
the proximal-mid section, extending approximately 6.9cm
distally and compressing the right atrium (Figure 2(a)).
The patient was referred to our institution, and coronary
angiography conﬁrmed an aneurysm (Figure 2(b)) in the
SVG with TIMI 2 ﬂow to the right PDA. A discussion
was held with cardiothoracic surgery as well as several staﬀ
members on several options. Coronary artery bypass surgery
was felt too high risk given history of thrombocytopenia,
chronic kidney disease as well as the enlarging aneurysm
in setting of a second open heart operation. Coiling the
aneurysm was not practical due to the fusiform nature of the
aneurysm.
2.2. Procedure. A percutaneous approach was chosen with
use of a Viabahn self expanding nitinol polyethylene tereph-
thalate (PET) covered stents (W. L. Gore and Associates,
Newark, DE). Viabahn PET covered stents were considered
to have suﬃcient length to cover the aneurysm and have
been proven successful in treatment of peripheral arterial
aneurysms [14]. The stents typically are delivered via only
the 7- or 8-French sheath without use of a guide catheter2 Cardiology Research and Practice
Figure 1: Viabahn PET covered stents. Picture provided by W. L. Gore and Associates.
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Figure 2: (a) Computer tomography (CT) in January 2008 of chest revealing a 3.1cm × 6.9cm aneurysm with contrast ﬁlling the inner
lumen, and possible thrombus ﬁlling the remaining space within the aneurysm. (b) Coronary angiography depicting the aneurysm of the
mid SVG, with TIMI 2 ﬂow in right posterior descending artery (PDA) in both right anterior oblique (RAO) and left anterior oblique (LAO)
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Figure 3: (a) Placement of the Viabahn self expanding stent with two guidewires in distal SVG and no guide catheter. (b) Coronary
angiography after placement of the stents with residual contrast entrapped in the aneurysm (arrows) in both RAO and LAO views with
TIMI 3 ﬂow in PDA.
and passed over the large 0.035 inch wire for support.
As the inner lumen of an 8-F sheath is larger than an
8-F guide, the use of a larger guide could increase the
risk for bleeding in the femoral artery access site. In
addition, the use of a 0.035-inch guide wire could be more
challenging to place in the coronary artery downstream
of the aneurysm due to risk for embolization of debris
from the aneurysm. To accommodate, we used a long
55cm length 8-French Brite Tip sheath (Cordis, Johnson
and Johnson, Miami Lakes, Fl) rather than a larger guide
catheter but lost the capability of directly injecting contrast
in the SVG to properly visualize the placement of the stents.
A5 m m × 5cm followed by a 5mm× 2.5cm covered
stents were delivered over two wires, an Asahi Prowater
coronary guide wire (Abbot Laboratories, Abbott Park, IL)
and an Ironman coronary guide wire (Abbot Laboratories,
Abbott Park, IL) rather than one large 0.035 inch guide wire
(Figure 3(a)). We considered using a distal protection device,
but were unable to pass the ﬁlter wire without concern for
embolization of debris from within the aneurysm. There
was a small section of the aneurysm not covered by the
two Viabahn PET covered stents and a 4mm × 16mm
Jostent GraftMaster polytetraﬂouroethylene (PTFE) covered
stent (Abbot Laboratories, Abbott Park, IL). A 4.5mm ×
16mm Liberte bare metal stent (Boston Scientiﬁc, Maple
Grove, MN) was deployed to overlap the Viabahn stent and
post dilated with Mavrick XL 5.5mm × 15mm balloon
(Boston Scientiﬁc, Maple Grove, MN). Final images revealed
entrapment of contrast in the aneurysm and TIMI 3
ﬂow in PDA (Figure 3(b)). The patient had an uneventful4 Cardiology Research and Practice
ECG coronal MIP 6 × 3 −450 ms
C: optiray
Se: 8/8
Im: 38/85
Cor: A169.1 (COl)
6.9 cm
DFOV: 41.5 × 41.5 cm
RL A
2008 Apr 07
Acq Tm: 11:41:06.004220
67 bpm, −450 ms
512 × 512
B31f
S
I
120.0 kV
345.0 mA
Tilt: 0.0
0.2 s
W: 500  L: 230
3.1 cm
P
(a)
Filter: enhance 5 4/7/2008 1:20:44 PM
1000
1
5
141/341
Filter: enhance 5 4/7/2008 1:20:44 PM
1000
1
4
146/419
33.50 LAO
3.90 CRA
36.50 RAO
3.40 CRA
(b)
Figure 4: (a) CT of the chest in April 2008 revealing aneurysm size (3.1cm × 6.9cm) has remained unchanged. (b) Coronary angiography
in April 2008 in both RAO and LAO views revealing patent stents and no evidence of leak through the covered stents into aneurysm.
hospital course and was discharged with no further chest
pain.
2.3. Follow-Up. He returned in April 2008 for follow-up
CT scan and coronary angiography and reported being
pain free and edema had not returned. CT scan revealed
that the aneurysm remained unchanged at 3.1cm × 6.9cm
(Figure 4(a)) in size. No contrast was visualized outside the
lumen, and no severe lesions were seen within the covered
stents (Figure 4(b)). At one year he remained asymptomatic
on clinical follow-up.
3. Discussion
Coronary aneurysms are deﬁned as a localized dilation of 1.5
times the diameter of the adjacent segment [15]. A fusiform
aneurysm is twice as long as it is wide versus the saccular,
which is larger in width than length. An ectatic coronary
artery is deﬁned as diﬀusely dilated greater than 50% of
arterial diameter [15]. Etiology of aneurysms of vein grafts
is not known but related to atherosclerosis, thrombosis,
and systolic and diastolic bidirectional blood ﬂow which
all could create and rapidly enlarge aneurysms [6, 16].
Unfortunately, some enlarge and cause pain, rupture withCardiology Research and Practice 5
possible ﬁstula formation, myocardial ischemia or compress
adjacent structures [2, 3]. This patient had both chest pain
and compression of adjacent structures by CT imaging. He
had no evidence for ischemia except for slow ﬂow in the
right PDA. The aneurysm was large but not considered
giant as it was not greater than 4cm in diameter [3]. The
aneurysm was both saccular in appearance in the proximal-
mid section and fusiform in the mid to distal section of
the graft (Figure 2(a)). The SVG placed twenty years earlier
had functioned well, documented by angiography four years
earlier, although appearing ectatic. Surgery would have
been preferred although one series reported no diﬀerence
in mortality on a retrospective analysis [17]. The authors
discuss a potential algorithm for management. In the setting
of symptoms, low operative risk and viable myocardium
endovascular repair or surgery is reasonable. In the setting
of high operative risk, endovascular exclusion/coiling with
or without percutaneous revascularization is reasonable. For
this patient, reoperation has inherent risks; in addition, if
the graft is not completely removed, a second aneurysm may
arise [3].
Several reports on transcatheter coil embolization have
been eﬀective for saccular aneurysms [4, 5]. An amplatzer
plughasbeenusedeﬀectivelytooccludeagiantsaccularSVG
aneurysm [6]. Use of a covered endograft in the ascending
aorta was used to occlude an SVG that had closed distal to an
enlarging aneurysm [7]. A vein covered stent was successful
in covering a saccular aneurysm in a saphenous vein graft
[8]. Several reports with PTFE covered stents have been
successful, including out to one year [9–13], although a large
false aneurysm was unsuccessfully covered by a PTFE-coated
stent [14]. A long aneurysm was ingeniously covered with
self expanding Wallstent initially as a scaﬀold, followed by
four PTFE covered stents; with the only caveat at six months
there was a residual leak that required an additional PTFE
covered stent [13]. We were able to cover the aneurysm
with two Viabahn PET covered self expanding stents and
one coronary PTFE covered stent. An important limitation
of this technique is lack of a guide catheter for adequate
viewing of the SVG aneurysm with contrast while placing
the peripheral stents, which we believe contributed to the
need for the additional coronary covered stent. In view of
this limitation, we believe that this approach should not be
considered routine for management of SVG aneurysms.
4. Conclusions
We report the successful coverage of this patient’s long SVG
aneurysmwithuseofViabahnselfexpandingnitinolcovered
stents over two wires via a 55cm sheath. His outcome
was stable by coronary angiography and CT scan at 4-
month postprocedure as well as clinical follow-up after
the intervention. We presume potential exists for further
aneurysmformation at the proximal and distal regions of the
SVG not covered by the stent. His medical therapy includes
antiplatelet agents as well as plaque stability with HMG-CoA
reductase inhibitors.
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